2008
DOI: 10.1016/j.matbio.2008.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
86
0
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 84 publications
(91 citation statements)
references
References 106 publications
(125 reference statements)
3
86
0
1
Order By: Relevance
“…In addition, under physiological conditions the release or degradation of these matrisome molecules was reported to contribute to cell signaling through their interactions with cell-surface molecules (45,49,50). Finally, selective degradation of PGs and GPs is known to contribute to cell adhesion and activation of cell proliferation (43,44,51,52).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, under physiological conditions the release or degradation of these matrisome molecules was reported to contribute to cell signaling through their interactions with cell-surface molecules (45,49,50). Finally, selective degradation of PGs and GPs is known to contribute to cell adhesion and activation of cell proliferation (43,44,51,52).…”
Section: Discussionmentioning
confidence: 99%
“…1,2,5 Decorin-Mediated Neutralization of TGF-␤ A great deal of attention has been focused on the antifibrotic properties of decorin as a neutralizing factor of TGF-␤, and decorin treatment exerts salutary effects in renal disorders involving TGF-␤ overproduction regardless of the mode of decorin administration. 9,21-24 Two decades of investigations confirmed the antifibrotic effects of decorin in several organs, such as kidney, lung, 25 heart, 26 skeletal muscle, 3 liver, 27 blood vessels, 28 skin, 29 and conjunctiva. 30 Several mechanisms of decorin-mediated inactivation of TGF-␤ are postulated, including physical interaction with TGF-␤ and interference with TGF-␤ signaling, either directly or indirectly by regulating other modulators of TGF-␤ activity, particularly fibrillin-1, myostatin, 3,8,[31][32][33] and formation of decorin/TGF-␤ complexes.…”
Section: Decorinmentioning
confidence: 99%
“…9,21-24 Two decades of investigations confirmed the antifibrotic effects of decorin in several organs, such as kidney, lung, 25 heart, 26 skeletal muscle, 3 liver, 27 blood vessels, 28 skin, 29 and conjunctiva. 30 Several mechanisms of decorin-mediated inactivation of TGF-␤ are postulated, including physical interaction with TGF-␤ and interference with TGF-␤ signaling, either directly or indirectly by regulating other modulators of TGF-␤ activity, particularly fibrillin-1, myostatin, 3,8,[31][32][33] and formation of decorin/TGF-␤ complexes. The latter are eliminated from the tissue through the circulation, by urinary excretion, or in the presence of collagen type I sequestration by the ECM ( Figure 1).…”
Section: Decorinmentioning
confidence: 99%
See 1 more Smart Citation
“…27 The relatively small size of the protein core (up to 42 kDa) is another hallmark of this class of proteoglycans, explaining why these compounds are referred to as small leucine-rich proteoglycans. 18,[28][29][30] SLRPs are covalently substituted with glycosaminoglycan (GAG) side chains: chondroitin sulfate, dermatan sulfate or keratan sulfate. The various lengths and states of sulfation contribute to the structural complexity of these molecules.…”
Section: The Family Of Small Leucine-rich Proteoglycansmentioning
confidence: 99%